市場調査レポート

商品コード

1701297

連続バイオプロセスの市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント予測、2025年～2030年

Continuous Bioprocessing Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables & Reagents), By Application (Monoclonal Antibodies, Vaccines), By End Use, By Region, And Segment Forecasts, 2025 - 2030

出版日: 2025年03月11日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日

カスタマイズ可能

価格

Unprintable PDF & Excel (Single User License)

USD 5,950 874,590円

レポートPDF及びExcelを1名様のみがご利用頂けるライセンスです。テキスト等のコピー＆ペースト、印刷はできません。

Printable PDF & Excel (5-User License)

USD 6,950 1,021,580円

レポートPDF及びExcelを同一企業内の同一部署における5名様までの方にご利用頂けるライセンスです。テキスト等のコピー＆ペースト、印刷は可能です。

Printable PDF & Excel (Enterprise License)

USD 8,950 1,315,560円

レポートの購入企業、およびその子会社、関連会社の方にご使用頂けるライセンスです。PDF及びExcelのテキスト等のコピー＆ペースト、印刷は可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

連続バイオプロセス市場の成長と動向：

Grand View Research, Incの最新レポートによると、世界の連続バイオプロセス市場規模は2030年までに9億1,143万米ドルに達し、2025年から2030年までのCAGRは18.63％で成長すると予測されています。

連続バイオプロセス市場は、生物製剤、バイオシミラー、細胞・遺伝子治療やモノクローナル抗体（mAbs）などの先端治療に対する需要の増加が原動力となっています。製薬・バイオテクノロジー企業がより高い効率性、コスト削減、生産サイクルの高速化を求める中、連続バイオプロセスが重要なソリューションとして浮上しています。従来のバッチ処理と比較して、連続バイオプロセスは高い生産性、優れた拡張性、改善されたプロセス制御を提供し、大規模な生物製剤製造に不可欠となっています。さらに、シングルユース・バイオリアクター、灌流ベースシステム、プロセス分析技術（PAT）の進歩が、業界全体で連続バイオプロセスの採用を加速しています。

COVID-19パンデミックは、迅速なワクチン生産、スケーラブルな製造、効率的なサプライチェーンへのニーズが高まる中、連続バイオプロセス導入の大きなきっかけとなりました。mRNAワクチン、モノクローナル抗体、抗ウイルス療法を開発する企業は、高い製品品質を維持しながら世界の需要を満たすため、連続バイオプロセスに目を向けた。パンデミックはまた、従来のバッチ処理の脆弱性を浮き彫りにし、柔軟性、拡張性、自動化された連続バイオ製造ソリューションへの投資の増加につながりました。その結果、パンデミック後、多くのバイオ製薬企業は連続バイオプロセス技術への投資を継続し、世界なバイオ製造における長期的な市場成長と回復力を確保しています。

バイオ製薬企業、CMO、規制当局間の協力関係の強化も市場成長の原動力となっています。FDAやEMAなどの規制機関は、ガイドラインやインセンティブ、より迅速な承認経路を提供することで、連続製造へのシフトを積極的に支援しています。さらに、主要企業は自動化、AI主導のプロセスモニタリング、リアルタイム分析に多額の投資を行い、製造ワークフローをさらに最適化しています。連続クロマトグラフィー、インライン品質管理、モジュール式バイオリアクターシステムの統合は、生物製剤製造を合理化し、ばらつきを減らし、一貫した製品品質を保証しています。

連続バイオプロセス市場のレポートハイライト

製品別では、消耗品と試薬が2024年の市場を独占。従来のバッチ処理から連続バイオプロセスへの移行により、連続バイオプロセス用消耗品・試薬の需要が拡大しています。
用途別では、モノクローナル抗体分野が市場を席巻し、2024年の売上高シェアは29.98%で最大となりました。バイオシミラーへのシフトや、プロセス強化に対する規制当局のサポートは、製品の純度や力価を高く維持しながら生産コストを削減しようとするメーカーにとって、採用をさらに後押ししています。
最終用途別では、製薬・バイオテクノロジー企業が市場を独占し、2024年の収益シェアは48.43%で最大となりました。FDAやEMAのような機関から、継続的な製造やプロセスの強化に関する規制上のサポートを受けていることが、バイオ製薬企業による次世代バイオプロセシング・ソリューションへの投資をさらに後押ししています。
2024年には、北米が市場をリードし、37.46%の最大収益シェアを占めました。この優位性は、バイオ医薬品の研究開発への多額の投資、確立された製造インフラ、高度なバイオプロセス技術を支援する有利な規制政策が後押ししています。

製品のセグメントダッシュボード
連続バイオプロセス市場：製品の変動分析
連続バイオプロセス市場の規模と動向分析（製品別、2018～2030年）
機器
- 機器市場推計・予測、2018年から2030年
- バイオリアクター
- ろ過システム
- クロマトグラフィーシステム
- プロセス分析技術
- その他
消耗品と試薬
- 消耗品と試薬市場推計・予測、2018年から2030年
- メディアとバッファ
- フィルターと膜
- 樹脂
- チューブとバッグ
- その他

第5章連続バイオプロセス：用途の推定・動向分析

用途のセグメントダッシュボード
連続バイオプロセス市場：用途変動分析
連続バイオプロセス市場の規模と動向分析（用途別、2018～2030年）
モノクローナル抗体
ワクチン
細胞・遺伝子治療
研究開発
その他の用途

第6章連続バイオプロセス：最終用途の推定・動向分析

最終用途セグメントダッシュボード
連続バイオプロセス市場：最終用途変動分析
連続バイオプロセス市場の規模と動向分析（最終用途別、2018～2030年）
製薬・バイオテクノロジー企業
CMOとCRO
研究・学術機関

第7章連続バイオプロセス：地域の推定・動向分析

地域市場ダッシュボード
地域別市場シェア分析、2024年および2030年
地域別連続バイオプロセス市場：主なポイント
北米
- 北米市場推計・予測、2018年～2030年
- 米国
- カナダ
- メキシコ
欧州
- 欧州市場推計・予測、2018年-2030年
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- スウェーデン
- ノルウェー
- デンマーク
アジア太平洋
- アジア太平洋市場推計・予測、2018年～2030年
- 日本
- 中国
- インド
- オーストラリア
- タイ
- 韓国
ラテンアメリカ
- ラテンアメリカ市場推計・予測、2018年-2030年
- ブラジル
- アルゼンチン
中東・アフリカ
- 中東・アフリカ市場推計・予測、2018年～2030年
- サウジアラビア
- 南アフリカ
- アラブ首長国連邦
- クウェート

第8章競合情勢

参入企業の分類
企業市況分析、2024年
参入企業概要
- Danaher
- Sartorius AG
- Thermo Fisher Scientific Inc.
- WuXi Biologics
- Ginkgo Bioworks
- Merck KGaA
- GE Healthcare
- Repligen Corporation
- Asahi Kasei Bioprocess America, Inc.

図表

List of Tables

Table 1 List of abbreviations
Table 2 Global Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 3 Global Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
Table 4 Global Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
Table 5 Global Continuous bioprocessing market, by region, 2018 - 2030 (USD Million)
Table 6 North America Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 7 North America Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
Table 8 North America Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
Table 9 North America Continuous bioprocessing market, by country, 2018 - 2030 (USD Million)
Table 10 U.S. Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 11 U.S. Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
Table 12 U.S. Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
Table 13 Canada Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 14 Canada Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
Table 15 Canada Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
Table 16 Mexico Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 17 Mexico Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
Table 18 Mexico Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
Table 19 Europe Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 20 Europe Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
Table 21 Europe Continuous bioprocessing market, by country, 2018 - 2030 (USD Million)
Table 22 Europe Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
Table 23 Germany Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 24 Germany Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
Table 25 Germany Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
Table 26 UK Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 27 UK Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
Table 28 UK Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
Table 29 France Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 30 France Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
Table 31 France Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
Table 32 Italy Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 33 Italy Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
Table 34 Italy Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
Table 35 Spain Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 36 Spain Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
Table 37 Spain Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
Table 38 Sweden Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 39 Sweden Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
Table 40 Sweden Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
Table 41 Norway Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 42 Norway Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
Table 43 Norway Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
Table 44 Denmark Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 45 Denmark Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
Table 46 Denmark Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Continuous bioprocessing market, by country, 2018 - 2030 (USD Million)
Table 51 China Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 52 China Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
Table 53 China Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
Table 54 Japan Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 55 Japan Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
Table 56 Japan Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
Table 57 India Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 58 India Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
Table 59 India Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
Table 60 Australia Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 61 Australia Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
Table 62 Australia Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
Table 63 Thailand Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 64 Thailand Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
Table 65 Thailand Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
Table 66 South Korea Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 67 South Korea Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
Table 68 South Korea Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
Table 69 Latin America Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 70 Latin America Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
Table 71 Latin America Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
Table 72 Latin America Continuous bioprocessing market, by country, 2018 - 2030 (USD Million)
Table 73 Brazil Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 74 Brazil Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
Table 75 Brazil Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
Table 76 Argentina Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 77 Argentina Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
Table 78 Argentina Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
Table 79 Middle East and Africa Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 80 Middle East and Africa Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
Table 81 Middle East and Africa Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
Table 82 Middle East and Africa Continuous bioprocessing market, by country, 2018 - 2030 (USD Million)
Table 83 South Africa Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 84 South Africa Continuous bioprocessing market, by automation type, 2018 - 2030 (USD Million)
Table 85 South Africa Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
Table 86 South Africa Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
Table 89 Saudi Arabia Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
Table 90 UAE Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 91 UAE Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
Table 92 UAE Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
Table 93 Kuwait Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 94 Kuwait Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
Table 95 Kuwait Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Continuous Bioprocessing: market outlook
Fig. 9 Continuous Bioprocessing competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Industry value chain analysis
Fig. 13 Continuous bioprocessing market driver impact
Fig. 14 Continuous bioprocessing market restraint impact
Fig. 15 Continuous bioprocessing market: Product movement analysis
Fig. 16 Continuous bioprocessing market: Product outlook and key takeaways
Fig. 17 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Bioreactors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Filtration systems market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Chromatography systems market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Process analytical technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Consumables & reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Media & buffers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Filters & membranes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Resin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Tubing & Bags market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Continuous bioprocessing market: Application movement analysis
Fig. 30 Continuous bioprocessing market: Application outlook and key takeaways
Fig. 31 Monoclonal antibodies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Cell and gene therapy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Research & Development market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Other Applications market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Continuous bioprocessing market: End use movement analysis
Fig. 37 Continuous bioprocessing market: End use outlook and key takeaways
Fig. 38 Pharmaceutical and biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 CMOs and CROs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Research and academic institutes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Global Continuous bioprocessing market: Regional movement analysis
Fig. 42 Global Continuous bioprocessing market: Regional outlook and key takeaways
Fig. 43 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Product Code: GVR-4-68040-535-2

Continuous Bioprocessing Market Growth & Trends:

The global continuous bioprocessing market size is anticipated to reach USD 911.43 million by 2030, growing at a CAGR of 18.63% from 2025 to 2030, according to a new report by Grand View Research, Inc. The continuous bioprocessing market is driven by the increasing demand for biologics, biosimilars, and advanced therapies such as cell and gene therapies and monoclonal antibodies (mAbs). As pharmaceutical and biotechnology companies seek higher efficiency, reduced costs, and faster production cycles, continuous bioprocessing has emerged as a key solution. Compared to traditional batch processing, continuous bioprocessing offers higher productivity, better scalability, and improved process control, making it essential for large-scale biologics manufacturing. Additionally, advancements in single-use bioreactors, perfusion-based systems, and process analytical technologies (PAT) are accelerating the adoption of continuous bioprocessing across the industry.

The COVID-19 pandemic acted as a major catalyst for the adoption of continuous bioprocessing, as the need for rapid vaccine production, scalable manufacturing, and efficient supply chains intensified. Companies developing mRNA vaccines, monoclonal antibodies, and antiviral therapies turned to continuous bioprocessing to meet global demand while maintaining high product quality. The pandemic also highlighted vulnerabilities in traditional batch processing, leading to increased investments in flexible, scalable, and automated continuous biomanufacturing solutions. As a result, post-pandemic, many biopharma companies have continued to invest in continuous bioprocessing technologies, ensuring long-term market growth and resilience in global biomanufacturing.

The increasing collaboration between biopharma companies, CMOs, and regulatory agencies is also driving market growth. Regulatory bodies such as the FDA and EMA have been actively supporting the shift towards continuous manufacturing by providing guidelines, incentives, and faster approval pathways. Moreover, key players are investing heavily in automation, AI-driven process monitoring, and real-time analytics, further optimizing production workflows. The integration of continuous chromatography, inline quality control, and modular bioreactor systems is streamlining biologics manufacturing, reducing variability, and ensuring consistent product quality.

Continuous Bioprocessing Market Report Highlights:

Based on product, consumables & reagents dominated the market in 2024. The shift from traditional batch processing to continuous bioprocessing has led to a growing demand for continuous bioprocessing consumables& reagents
Based on application, the monoclonal antibodies segment dominated the market, with the largest revenue share of 29.98% in 2024. The shift toward biosimilars and regulatory support for process intensification further fuel adoption, as manufacturers seek to reduce production costs while maintaining high product purity and potency
Based on end use, pharmaceutical and biotechnology companies dominated the market, with the largest revenue share of 48.43% in 2024. The regulatory support from agencies like the FDA and EMA for continuous manufacturing and process intensification is further encouraging biopharma firms to invest in next-generation bioprocessing solutions
In 2024, North America led the market, accounting for the largest revenue share of 37.46%. This dominance is fueled by significant investments in biopharmaceutical R&D, a well-established manufacturing infrastructure, and favorable regulatory policies supporting advanced bioprocessing technologies.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Application
- 1.1.3. End Use
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
1.4. Information or Data Analysis
- 1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Continuous bioprocessing market Variables and Trends

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Drivers
  - 3.2.1.1. Growing Demand for Biologics & Biosimilars
  - 3.2.1.2. Technological Advancements & Single-Use Systems
- 3.2.2. Restraints
  - 3.2.2.1. High Initial Investment & Process Complexity
3.3. Industry Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis

Chapter 4. Continuous Bioprocessing: Product Estimates & Trend Analysis

4.1. Product Segment Dashboard
4.2. Continuous bioprocessing market: Product Movement Analysis
4.3. Continuous bioprocessing market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Instruments
- 4.4.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.2. Bioreactors
  - 4.4.2.1. Bioreactors market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.3. Filtration Systems
  - 4.4.3.1. Filtration systems market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.4. Chromatography Systems
  - 4.4.4.1. Chromatography systems market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.5. Process Analytical Technologies
  - 4.4.5.1. Process analytical technologies market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.6. Others
  - 4.4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Consumables & Reagents
- 4.5.1. Consumables & reagents market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.2. Media & Buffers
  - 4.5.2.1. Media & buffers market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.3. Filters & Membranes
  - 4.5.3.1. Filters & membranes market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.4. Resin
  - 4.5.4.1. Resin market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.5. Tubing & Bags
  - 4.5.5.1. Tubing & bags market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.6. Other
  - 4.5.6.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Continuous Bioprocessing: Application Estimates & Trend Analysis

5.1. Application Segment Dashboard
5.2. Continuous bioprocessing market: Application Movement Analysis
5.3. Continuous bioprocessing market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Monoclonal antibodies
- 5.4.1. Monoclonal antibodies market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Vaccines
- 5.5.1. Vaccines market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Cell and gene therapy
- 5.6.1. Cell and gene therapy market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Research & Development
- 5.7.1. Research & development market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. Other Applications
- 5.8.1. Other applications market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Continuous Bioprocessing: End Use Estimates & Trend Analysis

6.1. End Use Segment Dashboard
6.2. Continuous bioprocessing market: End Use Movement Analysis
6.3. Continuous bioprocessing market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Pharmaceutical & Biotechnology Companies
- 6.4.1. Pharmaceutical and biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. CMOs and CROs
- 6.5.1. CMOs and CROs market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Research and Academic Institutes
- 6.6.1. Research and academic institutes market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Continuous Bioprocessing: Regional Estimates & Trend Analysis

7.1. Regional Market Dashboard
7.2. Regional Market Share Analysis, 2024 & 2030
7.3. Continuous bioprocessing market by Region: Key Takeaways
7.4. North America
- 7.4.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.2. U.S.
  - 7.4.2.1. Key Country Dynamics
  - 7.4.2.2. Competitive Scenario
  - 7.4.2.3. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.3. Canada
  - 7.4.3.1. Key Country Dynamics
  - 7.4.3.2. Competitive Scenario
  - 7.4.3.3. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.4. Mexico
  - 7.4.4.1. Key Country Dynamics
  - 7.4.4.2. Competitive Scenario
  - 7.4.4.3. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5. Europe
- 7.5.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.2. UK
  - 7.5.2.1. Key Country Dynamics
  - 7.5.2.2. Competitive Scenario
  - 7.5.2.3. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.3. Germany
  - 7.5.3.1. Key Country Dynamics
  - 7.5.3.2. Competitive Scenario
  - 7.5.3.3. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.4. France
  - 7.5.4.1. Key Country Dynamics
  - 7.5.4.2. Competitive Scenario
  - 7.5.4.3. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.5. Italy
  - 7.5.5.1. Key Country Dynamics
  - 7.5.5.2. Competitive Scenario
  - 7.5.5.3. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.6. Spain
  - 7.5.6.1. Key Country Dynamics
  - 7.5.6.2. Competitive Scenario
  - 7.5.6.3. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.7. Sweden
  - 7.5.7.1. Key Country Dynamics
  - 7.5.7.2. Competitive Scenario
  - 7.5.7.3. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.8. Norway
  - 7.5.8.1. Key Country Dynamics
  - 7.5.8.2. Competitive Scenario
  - 7.5.8.3. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.9. Denmark
  - 7.5.9.1. Key Country Dynamics
  - 7.5.9.2. Competitive Scenario
  - 7.5.9.3. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6. Asia Pacific
- 7.6.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.2. Japan
  - 7.6.2.1. Key Country Dynamics
  - 7.6.2.2. Competitive Scenario
  - 7.6.2.3. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.3. China
  - 7.6.3.1. Key Country Dynamics
  - 7.6.3.2. Competitive Scenario
  - 7.6.3.3. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.4. India
  - 7.6.4.1. Key Country Dynamics
  - 7.6.4.2. Competitive Scenario
  - 7.6.4.3. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.5. Australia
  - 7.6.5.1. Key Country Dynamics
  - 7.6.5.2. Competitive Scenario
  - 7.6.5.3. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.6. Thailand
  - 7.6.6.1. Key Country Dynamics
  - 7.6.6.2. Competitive Scenario
  - 7.6.6.3. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.7. South Korea
  - 7.6.7.1. Key Country Dynamics
  - 7.6.7.2. Competitive Scenario
  - 7.6.7.3. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7. Latin America
- 7.7.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.2. Brazil
  - 7.7.2.1. Key Country Dynamics
  - 7.7.2.2. Competitive Scenario
  - 7.7.2.3. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.3. Argentina
  - 7.7.3.1. Key Country Dynamics
  - 7.7.3.2. Competitive Scenario
  - 7.7.3.3. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.8. MEA
- 7.8.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.8.2. Saudi Arabia
  - 7.8.2.1. Key Country Dynamics
  - 7.8.2.2. Competitive Scenario
  - 7.8.2.3. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.8.3. South Africa
  - 7.8.3.1. Key Country Dynamics
  - 7.8.3.2. Competitive Scenario
  - 7.8.3.3. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.8.4. UAE
  - 7.8.4.1. Key Country Dynamics
  - 7.8.4.2. Competitive Scenario
  - 7.8.4.3. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.8.5. Kuwait
  - 7.8.5.1. Key Country Dynamics
  - 7.8.5.2. Competitive Scenario
  - 7.8.5.3. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

8.1. Participant Categorization
8.2. Company Market Position Analysis, 2024
8.3. Participant Overview
- 8.3.1. Danaher
  - 8.3.1.1. Company overview
  - 8.3.1.2. Financial performance
  - 8.3.1.3. Product benchmarking
  - 8.3.1.4. Strategic initiatives
- 8.3.2. Sartorius AG
  - 8.3.2.1. Company overview
  - 8.3.2.2. Financial performance
  - 8.3.2.3. Product benchmarking
  - 8.3.2.4. Strategic initiatives
- 8.3.3. Thermo Fisher Scientific Inc.
  - 8.3.3.1. Company overview
  - 8.3.3.2. Financial performance
  - 8.3.3.3. Product benchmarking
  - 8.3.3.4. Strategic initiatives
- 8.3.4. WuXi Biologics
  - 8.3.4.1. Company overview
  - 8.3.4.2. Financial performance
  - 8.3.4.3. Product benchmarking
  - 8.3.4.4. Strategic initiatives
- 8.3.5. Ginkgo Bioworks
  - 8.3.5.1. Company overview
  - 8.3.5.2. Financial performance
  - 8.3.5.3. Product benchmarking
  - 8.3.5.4. Strategic initiatives
- 8.3.6. Merck KGaA
  - 8.3.6.1. Company overview
  - 8.3.6.2. Financial performance
  - 8.3.6.3. Product benchmarking
  - 8.3.6.4. Strategic initiatives
- 8.3.7. GE Healthcare
  - 8.3.7.1. Company overview
  - 8.3.7.2. Financial performance
  - 8.3.7.3. Product benchmarking
  - 8.3.7.4. Strategic initiatives
- 8.3.8. Repligen Corporation
  - 8.3.8.1. Company overview
  - 8.3.8.2. Financial performance
  - 8.3.8.3. Product benchmarking
  - 8.3.8.4. Strategic initiatives
- 8.3.9. Asahi Kasei Bioprocess America, Inc.
  - 8.3.9.1. Company overview
  - 8.3.9.2. Financial performance
  - 8.3.9.3. Product benchmarking
  - 8.3.9.4. Strategic initiatives

連続バイオプロセスの市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント予測、2025年～2030年

Continuous Bioprocessing Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables & Reagents), By Application (Monoclonal Antibodies, Vaccines), By End Use, By Region, And Segment Forecasts, 2025 - 2030

連続バイオプロセス市場の成長と動向：

連続バイオプロセス市場のレポートハイライト

目次

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章連続バイオプロセス市場の変数と動向

第4章連続バイオプロセス：製品の推定・動向分析

第5章連続バイオプロセス：用途の推定・動向分析

第6章連続バイオプロセス：最終用途の推定・動向分析

第7章連続バイオプロセス：地域の推定・動向分析

第8章競合情勢

List of Tables

List of Figures

Continuous Bioprocessing Market Growth & Trends:

Continuous Bioprocessing Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Continuous bioprocessing market Variables and Trends

Chapter 4. Continuous Bioprocessing: Product Estimates & Trend Analysis

Chapter 5. Continuous Bioprocessing: Application Estimates & Trend Analysis

Chapter 6. Continuous Bioprocessing: End Use Estimates & Trend Analysis

Chapter 7. Continuous Bioprocessing: Regional Estimates & Trend Analysis

Chapter 8. Competitive Landscape

連続バイオプロセスの市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント予測、2025年～2030年

Continuous Bioprocessing Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables & Reagents), By Application (Monoclonal Antibodies, Vaccines), By End Use, By Region, And Segment Forecasts, 2025 - 2030

連続バイオプロセス市場の成長と動向：

連続バイオプロセス市場のレポートハイライト

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 連続バイオプロセス市場の変数と動向

第4章 連続バイオプロセス：製品の推定・動向分析

第5章 連続バイオプロセス：用途の推定・動向分析

第6章 連続バイオプロセス：最終用途の推定・動向分析

第7章 連続バイオプロセス：地域の推定・動向分析

第8章 競合情勢

List of Tables

List of Figures

Continuous Bioprocessing Market Growth & Trends:

Continuous Bioprocessing Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Continuous bioprocessing market Variables and Trends

Chapter 4. Continuous Bioprocessing: Product Estimates & Trend Analysis

Chapter 5. Continuous Bioprocessing: Application Estimates & Trend Analysis

Chapter 6. Continuous Bioprocessing: End Use Estimates & Trend Analysis

Chapter 7. Continuous Bioprocessing: Regional Estimates & Trend Analysis

Chapter 8. Competitive Landscape

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章連続バイオプロセス市場の変数と動向

第4章連続バイオプロセス：製品の推定・動向分析

第5章連続バイオプロセス：用途の推定・動向分析

第6章連続バイオプロセス：最終用途の推定・動向分析

第7章連続バイオプロセス：地域の推定・動向分析

第8章競合情勢